CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Favourable treatment of pyoderma gangrenosum with visilizumab in severe ulcerative colitis case
DOI 10.1055/s-2008-1079660
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Lőrincz, T Szalóki
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Pyoderma gangrenosum (PG) is a misleading designation for an idiopathic ulcerating cutaneous disease. More than 50% of patients do not have an associated disease. The incidence of PG in ulcerative colitis is low (1–5%), however 36–50% of all the patients have IBD. The activity of PG may or may not follow the activity of the bowel disease. Visilizumab (Nuvion, PDL Bio Pharma, USA) is a humanized IgG2 mono…
Zitieren
Zitierempfehlung
M Lőrincz, T Szalóki (2008) Favourable treatment of pyoderma gangrenosum with visilizumab in severe ulcerative colitis case. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2008-1079660
Mit CareLit weiterarbeiten